kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency, – Selective killing of cancer cells
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



